HomeTSHA • NASDAQ
add
Taysha Gene Therapies Inc
Previous close
$3.24
Day range
$3.04 - $3.27
Year range
$1.05 - $3.40
Market cap
837.48M USD
Avg Volume
3.19M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 1.99M | 78.60% |
Operating expense | 28.74M | 28.24% |
Net income | -26.88M | -28.45% |
Net profit margin | -1.35K | 28.08% |
Earnings per share | -0.08 | 0.95% |
EBITDA | -26.48M | -26.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 312.76M | 81.06% |
Total assets | 333.33M | 66.34% |
Total liabilities | 84.60M | -7.56% |
Total equity | 248.73M | — |
Shares outstanding | 272.79M | — |
Price to book | 3.56 | — |
Return on assets | -28.36% | — |
Return on capital | -31.46% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -26.88M | -28.45% |
Cash from operations | -20.18M | 6.15% |
Cash from investing | 62.00K | 130.85% |
Cash from financing | 216.29M | 206.93% |
Net change in cash | 196.17M | 302.29% |
Free cash flow | -9.79M | 27.49% |
About
Founded
2019
Headquarters
Website
Employees
73
